No Survival Benefit for Avastin in Glioblastoma (CME/CE)

No Survival Benefit for Avastin in Glioblastoma (CME/CE)

MedPage Today Neurology

(MedPage Today) -- First-line therapy for glioblastoma remained unchanged after two randomized trials showed no advantage to adding bevacizumab to the mix.

Original Article: http://www.medpagetoday.com/HematologyOncology/BrainCancer/44383

Julio Pereira, MD

Linkedin:http://www.linkedin.com/in/juliommais 

Site: www.neurocirurgiabr.com